MicroED Structures of Fluticasone Furoate and Fluticasone Propionate Provide New Insights into Their Function

被引:0
|
作者
Lin, Jieye [1 ]
Unge, Johan [2 ]
Gonen, Tamir [1 ]
机构
[1] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA
[2] Umea Univ, Dept Chem, Umea 90178, Sweden
基金
美国国家卫生研究院;
关键词
GLUCOCORTICOID-RECEPTOR; LIGAND-BINDING; TRANSLOCATION; PERFORMANCE; ENERGIES; INHALER; ATOMS; SET;
D O I
10.1021/acs.cgd.4c01683
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The detailed understanding of the conformational pathway of fluticasone, a widely prescribed medicine for allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD), from formulation to its protein-bound state, has been limited due to a lack of access to its high-resolution structures. The three-dimensional (3D) structure of fluticasone furoate 1 remains unpublished, and the deposited structure of fluticasone propionate 2 could be further refined due to refinement against new data. We applied microcrystal electron diffraction (MicroED) to determine the 3D structures of 1 and 2 in their solid states. The preferred geometries in solution were predicted by using density functional theory (DFT) calculations. A comparative analysis of the structures of 1 and 2 across three states (in solid state, in solution, and protein-bound conformation) revealed the course of the conformational changes during the entire transition. Potential energy plots were calculated for the most dynamic bonds, uncovering their rotational barriers. This study underscores the combined use of MicroED and DFT calculations to provide a comprehensive understanding of conformational and energy changes during drug administration. The quantitative comparison also highlights the subtle structural differences that may lead to significant changes in the pharmaceutical properties.
引用
收藏
页码:1588 / 1596
页数:9
相关论文
共 50 条
  • [21] Fluticasone Furoate, a Novel Inhaled Corticosteroid, Demonstrates Prolonged Lung Absorption Kinetics in Man Compared with Inhaled Fluticasone Propionate
    Allen, Ann
    Bareille, Philippe J.
    Rousell, Vicki M.
    CLINICAL PHARMACOKINETICS, 2013, 52 (01) : 37 - 42
  • [22] A patient preference evaluation study comparing the sensory attributes of fluticasone furoate nasal spray with fluticasone propionate nasal spray
    Meltzer, E.
    Stahlman, J.
    Leflein, J.
    Meltzer, S.
    Lim, J.
    Dalal, A.
    Prillaman, B.
    Philpot, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A89 - A90
  • [23] Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children
    de Blic, Jacques
    Ogorodova, Ludmila
    Klink, Rabih
    Sidorenko, Irina
    Valiulis, Arunas
    Hofman, Jerzy
    Bennedbaek, Olav
    Anderton, Sally
    Attali, Valerie
    Desfougeres, Jean-Luc
    Poterre, Marc
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2009, 20 (08) : 763 - 771
  • [24] Relative transactivation and transrepression potencies of fluticasone propionate (FP) and mometasone furoate (MF)
    Roumestan, C
    Henriquet, C
    Johnson, M
    Demoly, P
    Bousquet, J
    Mathieu, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S240 - S241
  • [25] A Comparison of the Efficacy of Once-Daily Fluticasone Furoate/Vilanterole with Twice-Daily Fluticasone Propionate/Salmeterol in Elderly Asthmatics
    Ishiura, Yoshihisa
    Fujimura, Masaki
    Shiba, Yasutaka
    Ohkura, Noriyuki
    Hara, Johsuke
    Abo, Miki
    Kasahara, Kazuo
    DRUG RESEARCH, 2018, 68 (01) : 38 - 44
  • [26] Efficacy of combination fluticasone furoate/vilanterol (FF/VI) and salmeterol/fluticasone propionate (SFC) over 12 weeks in patients with COPD
    Agusti, Alvar
    De Backer, Wilfried
    de Teresa, Luis
    Zvarich, Michael
    Locantore, Nick
    Barnes, Neil
    Bourbeau, Jean
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [27] Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate
    Wardlaw, A
    Larivee, P
    Eller, J
    Cockcroft, DW
    Ghaly, L
    Harris, AG
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (01) : 49 - 55
  • [28] Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial (vol 120, pg 78, 2016)
    Adachi, Mitsuru
    Goldfrad, Caroline
    Jacques, Loretta
    Nishimura, Yoshie
    RESPIRATORY MEDICINE, 2017, 126 : 25 - 25
  • [29] Fluticasone Propionate Combined With Montelukast Will Provide More Protection From Asthma Exacerbations During High Pollution Days Compared To Fluticasone Propionate alone
    Radford, P.
    Schoonmaker, A.
    Cook, S.
    Wilson, G.
    Harris, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [30] ADHERENCE WITH ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL COMPARED TO TWICE-DAILY BUDESONIDE/FORMOTEROL OR FLUTICASONE PROPIONATE/SALMETEROL IN ASTHMA
    Averell, C.
    Stanford, R.
    Laliberte, F.
    Wu, J.
    Germain, G.
    Duh, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S39 - S39